Miki C - Search Results

1

Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.

Tanaka K, Otake K, Mohri Y, Ohi M, Yokoe T, Toiyama Y, Miki C, Tonouchi H, Kusunoki M. Tanaka K, et al. Among authors: miki c. Oncol Rep. 2009 Jun;21(6):1489-94. doi: 10.3892/or_00000379. Oncol Rep. 2009. PMID: 19424628

2

5-FU improves p27-related poor prognosis in patients with Astler-Coller B2-C colorectal carcinoma.

Kobayashi M, Shiraishi T, Tonouchi H, Miki C, Kusunoki M. Kobayashi M, et al. Among authors: miki c. Oncol Rep. 2002 Jan-Feb;9(1):29-33. Oncol Rep. 2002. PMID: 11748451

3

The clinical implication of 14-3-3 sigma expression in primary gastrointestinal malignancy.

Tanaka K, Hatada T, Kobayashi M, Mohri Y, Tonouchi H, Miki C, Nobori T, Kusunoki M. Tanaka K, et al. Among authors: miki c. Int J Oncol. 2004 Dec;25(6):1591-7. Int J Oncol. 2004. PMID: 15547695

4

Gene expression profiles of colorectal carcinoma in response to neo-adjuvant chemotherapy.

Inoue Y, Shirane M, Miki C, Hiro J, Tanaka K, Kobayashi M, Mori K, Yanagi H, Kusunoki M. Inoue Y, et al. Among authors: miki c. Int J Oncol. 2004 Dec;25(6):1641-9. Int J Oncol. 2004. PMID: 15547701 Clinical Trial.

5

Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma.

Konishi N, Miki C, Yoshida T, Tanaka K, Toiyama Y, Kusunoki M. Konishi N, et al. Among authors: miki c. Oncology. 2005;68(2-3):138-45. doi: 10.1159/000086768. Epub 2005 Jul 4. Oncology. 2005. PMID: 16006751

6

Irinotecan cytotoxicity does not necessarily depend on the UGT1A1 polymorphism but on fluoropyrimidine: a molecular case report.

Inoue Y, Miki C, Watanabe H, Hiro J, Toiyama Y, Ojima E, Nakatani K, Nobori T, Kusunoki M. Inoue Y, et al. Among authors: miki c. Oncol Rep. 2006 Nov;16(5):971-4. Oncol Rep. 2006. PMID: 17016579

7

The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.

Ojima E, Inoue Y, Watanabe H, Hiro J, Toiyama Y, Miki C, Kusunoki M. Ojima E, et al. Among authors: miki c. Oncol Rep. 2006 Nov;16(5):1085-91. Oncol Rep. 2006. PMID: 17016597

8

Does preoperative chemo-radiotherapy enhance the expression of vascular endothelial growth factor in patients with rectal cancer?

Inoue Y, Ojima E, Watanabe H, Hiro J, Toiyama Y, Kobayashi M, Miki C, Kusunoki M. Inoue Y, et al. Among authors: miki c. Oncol Rep. 2007 Aug;18(2):369-75. Oncol Rep. 2007. PMID: 17611658

9

Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy.

Ojima E, Inoue Y, Miki C, Mori M, Kusunoki M. Ojima E, et al. Among authors: miki c. J Gastroenterol. 2007 Sep;42(9):730-6. doi: 10.1007/s00535-007-2089-x. Epub 2007 Sep 25. J Gastroenterol. 2007. PMID: 17876542

10

Alteration of the chemoresistant gene expression during chemotherapy for colon cancer: a molecular case report.

Toiyama Y, Inoue Y, Hiro J, Ojima E, Watanabe H, Miki C, Kusunoki M. Toiyama Y, et al. Among authors: miki c. Oncol Rep. 2008 Mar;19(3):755-9. Oncol Rep. 2008. PMID: 18288412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters